Kemp EH - Search Results

1

The transcription factors SOX9 and SOX10 are vitiligo autoantigens in autoimmune polyendocrine syndrome type I.

Hedstrand H, Ekwall O, Olsson MJ, Landgren E, Kemp EH, Weetman AP, Perheentupa J, Husebye E, Gustafsson J, Betterle C, Kämpe O, Rorsman F. Hedstrand H, et al. Among authors: kemp eh. J Biol Chem. 2001 Sep 21;276(38):35390-5. doi: 10.1074/jbc.M102391200. Epub 2001 Jun 22. J Biol Chem. 2001. PMID: 11423552 Free article.

2

Autoimmune aspects of vitiligo.

Kemp EH, Waterman EA, Weetman AP. Kemp EH, et al. Autoimmunity. 2001;34(1):65-77. doi: 10.3109/08916930108994127. Autoimmunity. 2001. PMID: 11681494 Free article. Review.

3

Detection of tyrosinase autoantibodies in patients with vitiligo using 35S-labeled recombinant human tyrosinase in a radioimmunoassay.

Kemp EH, Gawkrodger DJ, MacNeil S, Watson PF, Weetman AP. Kemp EH, et al. J Invest Dermatol. 1997 Jul;109(1):69-73. doi: 10.1111/1523-1747.ep12276556. J Invest Dermatol. 1997. PMID: 9204957 Free article.

4

Immunoprecipitation of melanogenic enzyme autoantigens with vitiligo sera: evidence for cross-reactive autoantibodies to tyrosinase and tyrosinase-related protein-2 (TRP-2).

Kemp EH, Gawkrodger DJ, Watson PF, Weetman AP. Kemp EH, et al. Clin Exp Immunol. 1997 Sep;109(3):495-500. doi: 10.1046/j.1365-2249.1997.4781381.x. Clin Exp Immunol. 1997. PMID: 9328128 Free PMC article.

5

Identification of epitopes on tyrosinase which are recognized by autoantibodies from patients with vitiligo.

Kemp EH, Waterman EA, Gawkrodger DJ, Watson PF, Weetman AP. Kemp EH, et al. J Invest Dermatol. 1999 Aug;113(2):267-71. doi: 10.1046/j.1523-1747.1999.00664.x. J Invest Dermatol. 1999. PMID: 10469315 Free article.

6

Autoimmunity as an aetiological factor in vitiligo.

Rezaei N, Gavalas NG, Weetman AP, Kemp EH. Rezaei N, et al. Among authors: kemp eh. J Eur Acad Dermatol Venereol. 2007 Aug;21(7):865-76. doi: 10.1111/j.1468-3083.2007.02228.x. J Eur Acad Dermatol Venereol. 2007. PMID: 17658994 Review.

7

Autoantibodies to human melanocyte-specific protein pmel17 in the sera of vitiligo patients: a sensitive and quantitative radioimmunoassay (RIA).

Kemp EH, Gawkrodger DJ, Watson PF, Weetman AP. Kemp EH, et al. Clin Exp Immunol. 1998 Dec;114(3):333-8. doi: 10.1046/j.1365-2249.1998.00746.x. Clin Exp Immunol. 1998. PMID: 9844040 Free PMC article.

8

Autoantibodies in vitiligo patients are not directed to the melanocyte differentiation antigen MelanA/MART1.

Waterman EA, Kemp EH, Gawkrodger DJ, Watson PF, Weetman AP. Waterman EA, et al. Among authors: kemp eh. Clin Exp Immunol. 2002 Sep;129(3):527-32. doi: 10.1046/j.1365-2249.2002.01949.x. Clin Exp Immunol. 2002. PMID: 12197895 Free PMC article.

9

Immunological pathomechanisms in vitiligo.

Kemp EH, Waterman EA, Weetman AP. Kemp EH, et al. Expert Rev Mol Med. 2001 Jul 23;3(20):1-22. doi: 10.1017/S1462399401003362. Expert Rev Mol Med. 2001. PMID: 14585144

10

Autoantibody responses to melanocytes in the depigmenting skin disease vitiligo.

Kemp EH, Gavalas NG, Gawkrodger DJ, Weetman AP. Kemp EH, et al. Autoimmun Rev. 2007 Jan;6(3):138-42. doi: 10.1016/j.autrev.2006.09.010. Epub 2006 Oct 2. Autoimmun Rev. 2007. PMID: 17289548 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

114 results

Search Page

Filters